1. Home
  2. SLVM vs BHVN Comparison

SLVM vs BHVN Comparison

Compare SLVM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sylvamo Corporation

SLVM

Sylvamo Corporation

HOLD

Current Price

$42.15

Market Cap

1.7B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.19

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLVM
BHVN
Founded
1898
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
SLVM
BHVN
Price
$42.15
$9.19
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$54.00
$29.08
AVG Volume (30 Days)
341.3K
2.0M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
4.31%
N/A
EPS Growth
N/A
26.08
EPS
3.24
N/A
Revenue
$3,351,000,000.00
N/A
Revenue This Year
$0.98
N/A
Revenue Next Year
$2.28
N/A
P/E Ratio
$12.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.09
$7.48
52 Week High
$62.02
$24.06

Technical Indicators

Market Signals
Indicator
SLVM
BHVN
Relative Strength Index (RSI) 48.76 46.02
Support Level $41.56 $8.08
Resistance Level $43.81 $10.22
Average True Range (ATR) 1.29 0.63
MACD 0.44 0.15
Stochastic Oscillator 84.71 54.93

Price Performance

Historical Comparison
SLVM
BHVN

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: